In a landmark move for women’s health, the U.S. Food and Drug Administration (FDA) has announced it will remove long-standing “black box” warnings from hormone replacement therapy (HRT) products used to treat menopause symptoms — a decision that could reshape how millions of women manage this life stage. The announcement came from the U.S. Health …
